LEONARDIS, DANIELA
LEONARDIS, DANIELA
Istituto di Fisiologia Clinica - IFC
A Genetic Marker of Uric Acid Level, Carotid Atherosclerosis, and Arterial Stiffness: A Family-Based Study
2015 Mallamaci, Francesca; Testa, Alessandra; Leonardis, Daniela; Tripepi, Rocco; Pisano, Anna; Spoto, BELINDA GILDA; Sanguedolce Maria, Cristina; Parlongo, ROSA MARIA TERESA; Tripepi, GIOVANNI LUIGI; Zoccali, Carmine
A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study
2014 Mallamaci, Francesca; Testa, Alessandra; Leonardis, Daniela; Tripepi, Rocco; Pisano, Anna; Spoto, Belinda; Sanguedolce, Maria Cristina; Parlongo, Rosa Maria; Tripepi, Giovanni; Zoccali, Carmine
A polymorphismin a major antioxidant gene (Kelch-like ECH-associated protein1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory study
2016 Testa, Alessandra; Leonardis, Daniela; Spoto, Belinda; Sanguedolce, Maria Cristina; Parlongo, Rosa M.; Pisano, Anna; Tripepi, Giovanni; Mallamaci, Francesca; Zoccali, Carmine
ADMA machinery is expressed in adipocytes in humans and it is differentially regulated in CKD and ESRD patients
2007 Spoto, B; Leonardis, D; Parlongo, G; Parlongo, Rm; Finocchiaro, P; Mallamaci, F; Tripepi, G; Zoccali, C
ANALISI STATISTICA DEI RAPPORTI TRA NEUROPEPTIDE Y, CROMOGRANINA ED EVENTI CLINICI NELLA COORTE DELLO STUDIO MAURO
2011 Darrigo, Graziella; Tripepi, GIOVANNI LUIGI; Leonardis, Daniela
Are derived equations to estimate Glomerular Filtration Rate (GFR) in Chronic Kidney Disease ( CKD) patients different in their prognostic value?
2010 Leonardis D.; Mallamaci F.; Catalano F.; Pisano A.; Mafrica A. ; Tripepi G.; Zoccali C. a nome del Gruppo
Association of a polymorphism in a gene encoding a urate transporter with ckd progression
2014 Testa A.; Mallamaci F.; Spoto B.; Pisano A.; Cristina Sanguedolce M.; Tripepi G.; Leonardis D.; Zoccali C.
Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD
2015 Spoto, B; Mattaceraso, F; Sijbrands, E; Leonardis, D; Testa, A; Pisano, A; Pizzini, P; Cutrupi, S; Parlongo, Rm; D'Arrigo, G; Tripepi, G; Mallamaci, F; Zoccali, C
Asymmetric Dimethylarginine (ADMA) Enzymatic Machinery and Adipokines Gene Expression in the Adipose Tissue in Stage 3-5 CKD patients.
2007 Spoto B.; Leonardis D.; Mallamaci F.; Parlongo R.; Pizzini P.; Tripepi G.; Zoccali C.
Audit clinico sulle principali aree di intervento della malattia renale cronica: verifica obiettivi linee guida su un campione rappresentativo della popolazione dello studio che ha concluso il periodo di osservazione.
2010 Leonardis, D
Audit sui principali indicatori di procurement e di efficienza del processo di donazione in Calabria.
2010 Leonardis, D
Beyond bone mineral metabolism: functional relationship with inflammation in chronic kidney disease (CKD) patients.
2009 Zoccali, C; Leonardis, D; Catalano, F; Caridi, G; Finocchiaro, P; Panuccio, V; Cutrupi, S; Pizzini, P; Tripepi, G; Mallamaci, F
Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial.
2005 Ruggenenti P; Perna A; Loriga G; Ganeva M; Iordache B; Turturro M; Lesti M; Perticucci E; Chakarski IN; Leonardis D; Garini G; Sessa A; Basile C; Alpa M; Scanziani R; Sorba G; Zoccali C; Remuzz G.
Circulating E-selectin as a risk marker in patients with end-stage renal disease
2007 Malatino LS; Stancanelli B; Cataliotti A;Bellanuova I; Fatuzzo P; Rapisarda F; Leonardis D; Tripepi G; Mallamaci F; Zoccali C.
Circulating soluble RAGE in patients with chronic kidney disease as an inverse correlate of atherosclerosis.
2009 Leonardis, D; Basta, G; Mallamaci, F; Cutrupi, S; Pizzini, P; De Caterina, R; Tripepi, R; Tripepi, G; Zoccali, C
Circulating soluble RAGE in patients with chronic kidney disease as an inverse correlate of atherosclerosis.
2009 Leonardis, D; Basta, G; Mallamaci, F; Cutrupi, S; Pizzini, P; De Caterina, R; Tripepi, R; Tripepi, G; Zoccali, C
Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD)
2012 Leonardis, D; Basta, G; Mallamaci, F; Cutrupi, S; Pizzini, P; Tripepi, R; Tripepi, G; De Caterina, R
Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease
2010 Basta, G; Leonardis, D; Mallamaci, F; Cutrupi, S; Pizzini, P; Gaetano, L; Tripepi, R; Tripepi, G; De Caterina, R; Zoccali, C
CKD-MBD biomarkers and CKD progression: an analysis by the joint model
2023 D'Arrigo, Graziella; Mallamaci, Francesca; Pizzini, Patrizia; Leonardis, Daniela; Tripepi, GIOVANNI LUIGI; Zoccali, Carmine
Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD.
2015 Tripepi, Giovanni; Kollerits, Barbara; Leonardis, Daniela; Ilker Yilmaz, Mahamut; Postorino, Maurizio; Fliser, Danilo; Mallamaci, Francesca; Kronenberg, Florian; Zoccali, Carmine
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A Genetic Marker of Uric Acid Level, Carotid Atherosclerosis, and Arterial Stiffness: A Family-Based Study | 1-gen-2015 | Mallamaci, Francesca; Testa, Alessandra; Leonardis, Daniela; Tripepi, Rocco; Pisano, Anna; Spoto, BELINDA GILDA; Sanguedolce Maria, Cristina; Parlongo, ROSA MARIA TERESA; Tripepi, GIOVANNI LUIGI; Zoccali, Carmine | |
A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study | 1-gen-2014 | Mallamaci, Francesca; Testa, Alessandra; Leonardis, Daniela; Tripepi, Rocco; Pisano, Anna; Spoto, Belinda; Sanguedolce, Maria Cristina; Parlongo, Rosa Maria; Tripepi, Giovanni; Zoccali, Carmine | |
A polymorphismin a major antioxidant gene (Kelch-like ECH-associated protein1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory study | 1-gen-2016 | Testa, Alessandra; Leonardis, Daniela; Spoto, Belinda; Sanguedolce, Maria Cristina; Parlongo, Rosa M.; Pisano, Anna; Tripepi, Giovanni; Mallamaci, Francesca; Zoccali, Carmine | |
ADMA machinery is expressed in adipocytes in humans and it is differentially regulated in CKD and ESRD patients | 1-gen-2007 | Spoto, B; Leonardis, D; Parlongo, G; Parlongo, Rm; Finocchiaro, P; Mallamaci, F; Tripepi, G; Zoccali, C | |
ANALISI STATISTICA DEI RAPPORTI TRA NEUROPEPTIDE Y, CROMOGRANINA ED EVENTI CLINICI NELLA COORTE DELLO STUDIO MAURO | 1-gen-2011 | Darrigo, Graziella; Tripepi, GIOVANNI LUIGI; Leonardis, Daniela | |
Are derived equations to estimate Glomerular Filtration Rate (GFR) in Chronic Kidney Disease ( CKD) patients different in their prognostic value? | 1-gen-2010 | Leonardis D.; Mallamaci F.; Catalano F.; Pisano A.; Mafrica A. ; Tripepi G.; Zoccali C. a nome del Gruppo | |
Association of a polymorphism in a gene encoding a urate transporter with ckd progression | 1-gen-2014 | Testa A.; Mallamaci F.; Spoto B.; Pisano A.; Cristina Sanguedolce M.; Tripepi G.; Leonardis D.; Zoccali C. | |
Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD | 1-gen-2015 | Spoto, B; Mattaceraso, F; Sijbrands, E; Leonardis, D; Testa, A; Pisano, A; Pizzini, P; Cutrupi, S; Parlongo, Rm; D'Arrigo, G; Tripepi, G; Mallamaci, F; Zoccali, C | |
Asymmetric Dimethylarginine (ADMA) Enzymatic Machinery and Adipokines Gene Expression in the Adipose Tissue in Stage 3-5 CKD patients. | 1-gen-2007 | Spoto B.; Leonardis D.; Mallamaci F.; Parlongo R.; Pizzini P.; Tripepi G.; Zoccali C. | |
Audit clinico sulle principali aree di intervento della malattia renale cronica: verifica obiettivi linee guida su un campione rappresentativo della popolazione dello studio che ha concluso il periodo di osservazione. | 1-gen-2010 | Leonardis, D | |
Audit sui principali indicatori di procurement e di efficienza del processo di donazione in Calabria. | 1-gen-2010 | Leonardis, D | |
Beyond bone mineral metabolism: functional relationship with inflammation in chronic kidney disease (CKD) patients. | 1-gen-2009 | Zoccali, C; Leonardis, D; Catalano, F; Caridi, G; Finocchiaro, P; Panuccio, V; Cutrupi, S; Pizzini, P; Tripepi, G; Mallamaci, F | |
Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. | 1-gen-2005 | Ruggenenti P; Perna A; Loriga G; Ganeva M; Iordache B; Turturro M; Lesti M; Perticucci E; Chakarski IN; Leonardis D; Garini G; Sessa A; Basile C; Alpa M; Scanziani R; Sorba G; Zoccali C; Remuzz G. | |
Circulating E-selectin as a risk marker in patients with end-stage renal disease | 1-gen-2007 | Malatino LS; Stancanelli B; Cataliotti A;Bellanuova I; Fatuzzo P; Rapisarda F; Leonardis D; Tripepi G; Mallamaci F; Zoccali C. | |
Circulating soluble RAGE in patients with chronic kidney disease as an inverse correlate of atherosclerosis. | 1-gen-2009 | Leonardis, D; Basta, G; Mallamaci, F; Cutrupi, S; Pizzini, P; De Caterina, R; Tripepi, R; Tripepi, G; Zoccali, C | |
Circulating soluble RAGE in patients with chronic kidney disease as an inverse correlate of atherosclerosis. | 1-gen-2009 | Leonardis, D; Basta, G; Mallamaci, F; Cutrupi, S; Pizzini, P; De Caterina, R; Tripepi, R; Tripepi, G; Zoccali, C | |
Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD) | 1-gen-2012 | Leonardis, D; Basta, G; Mallamaci, F; Cutrupi, S; Pizzini, P; Tripepi, R; Tripepi, G; De Caterina, R | |
Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease | 1-gen-2010 | Basta, G; Leonardis, D; Mallamaci, F; Cutrupi, S; Pizzini, P; Gaetano, L; Tripepi, R; Tripepi, G; De Caterina, R; Zoccali, C | |
CKD-MBD biomarkers and CKD progression: an analysis by the joint model | 1-gen-2023 | D'Arrigo, Graziella; Mallamaci, Francesca; Pizzini, Patrizia; Leonardis, Daniela; Tripepi, GIOVANNI LUIGI; Zoccali, Carmine | |
Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD. | 1-gen-2015 | Tripepi, Giovanni; Kollerits, Barbara; Leonardis, Daniela; Ilker Yilmaz, Mahamut; Postorino, Maurizio; Fliser, Danilo; Mallamaci, Francesca; Kronenberg, Florian; Zoccali, Carmine |